Innovation, industrial strength drive surge in China's AI product exports

Global Times: Here Come China's 'next new three': AI, robotics and innovative drugs spearhead a new round of…

China's "next new three"—AI, robotics, innovative drugs—drive new export growth: AI models +30.93% MoM, robotics $929M in H1 2026, pharma licensing $110B. This transition from cost-based manufacturing to innovation leadership reshapes global competition—CIOs must reassess vendor strategies and supply chain exposure to China's emerging tech hubs.